ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 56 filers reported holding ONCOCYTE CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $45,000 | -34.8% | 29,874 | -6.6% | 0.00% | – |
Q4 2021 | $69,000 | -41.0% | 31,978 | -2.9% | 0.00% | -100.0% |
Q3 2021 | $117,000 | -48.7% | 32,934 | -17.1% | 0.00% | 0.0% |
Q2 2021 | $228,000 | +5.6% | 39,708 | -4.4% | 0.00% | 0.0% |
Q1 2021 | $216,000 | +148.3% | 41,541 | +13.6% | 0.00% | – |
Q4 2020 | $87,000 | +67.3% | 36,564 | -2.8% | 0.00% | – |
Q3 2020 | $52,000 | +2.0% | 37,614 | +42.2% | 0.00% | – |
Q2 2020 | $51,000 | +59.4% | 26,457 | +99.7% | 0.00% | – |
Q1 2020 | $32,000 | +6.7% | 13,247 | -1.6% | 0.00% | – |
Q4 2019 | $30,000 | +3.4% | 13,460 | -0.8% | 0.00% | – |
Q3 2019 | $29,000 | -14.7% | 13,574 | -0.7% | 0.00% | – |
Q2 2019 | $34,000 | +580.0% | 13,668 | +456.5% | 0.00% | – |
Q1 2018 | $5,000 | -58.3% | 2,456 | -5.1% | 0.00% | – |
Q4 2017 | $12,000 | -33.3% | 2,588 | +7.3% | 0.00% | – |
Q3 2017 | $18,000 | +50.0% | 2,413 | +8.1% | 0.00% | – |
Q2 2017 | $12,000 | -99.8% | 2,233 | +46.5% | 0.00% | – |
Q1 2016 | $7,000,000 | – | 1,524 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 2,982,557 | $5,697,000 | 6.44% |
BROADWOOD CAPITAL INC | 14,716,204 | $28,108,000 | 2.20% |
PURA VIDA INVESTMENTS, LLC | 5,983,724 | $11,429,000 | 1.10% |
Mesirow Financial Investment Management, Inc. | 99,282 | $190,000 | 0.90% |
P.A.W. CAPITAL CORP | 200,000 | $382,000 | 0.43% |
Penbrook Management LLC | 215,625 | $412,000 | 0.40% |
EAM Investors, LLC | 241,769 | $462,000 | 0.10% |
Private Wealth Partners, LLC | 150,000 | $287,000 | 0.04% |
Phoenix Holdings Ltd. | 292,275 | $597,000 | 0.02% |
ETF MANAGERS GROUP, LLC | 145,650 | $470,000 | 0.02% |